Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezepelumab in Chronic Rhinosinusitis With Severe Asthma
NCT06740045Phase 3Not yet recruiting
- Sponsor
- Dr. Andrew Thamboo
- Start
- Jan 2025
- Primary completion
- Mar 2025
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of tezepelumab in chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, sponsored by Dr. Andrew Thamboo. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)asthma
Beyond the preview
Go deeper on NCT06740045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06740045.